{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T07:11:54Z","timestamp":1794381114117,"version":"4.9.0"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T00:00:00Z","timestamp":1696550400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004622","name":"KWF Kankerbestrijding","doi-asserted-by":"publisher","award":["13167"],"award-info":[{"award-number":["13167"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010790","name":"Erasmus+","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010790","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["\/ 200989\/2022\u20137"],"award-info":[{"award-number":["\/ 200989\/2022\u20137"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["3018770\/2019"],"award-info":[{"award-number":["3018770\/2019"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.biopha.2023.115663","type":"journal-article","created":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T11:34:49Z","timestamp":1697024089000},"page":"115663","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"special_numbering":"C","title":["Inhibition of murine colorectal cancer metastasis by targeting M2-TAM through STAT3\/NF-kB\/AKT signaling using macrophage 1-derived extracellular vesicles loaded with oxaliplatin, retinoic acid, and Libidibia ferrea"],"prefix":"10.1016","volume":"168","author":[{"given":"Tha\u00eds Gomes","family":"de Carvalho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Lara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Jorquera-Cordero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00edcero Fl\u00e1vio Soares","family":"Arag\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artur","family":"de Santana Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinicius Barreto","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirley Vit\u00f3ria","family":"de Paiva Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0948-6209","authenticated-orcid":false,"given":"Timo","family":"Schomann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz Alberto Lira","family":"Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo Marcos","family":"da Matta Guedes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raimundo Fernandes","family":"de Ara\u00fajo J\u00fanior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.biopha.2023.115663_bib1","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.3390\/ijms20102454","article-title":"Mechanism of apoptosis induced by curcumin in colorectal cancer","volume":"20","author":"Ismail","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2023.115663_bib2","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2015-310912","article-title":"Global patterns and trends in colorectal cancer incidence and mortality","author":"Arnold","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.biopha.2023.115663_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18010197","article-title":"Colorectal carcinoma: a general overview and future perspectives in colorectal cancer","author":"M\u00e1rmol","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.biopha.2023.115663_bib4","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.apsb.2015.07.005","article-title":"Cancer metastases: challenges and opportunities","volume":"5","author":"Guan","year":"2015","journal-title":"Acta Pharm. Sin. B."},{"key":"10.1016\/j.biopha.2023.115663_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2012.09.025","article-title":"Why does cancer therapy lack effective anti-metastasis drugs?","author":"Weber","year":"2013","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.biopha.2023.115663_bib6","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41392-020-0116-z","article-title":"Comprehensive review of targeted therapy for colorectal cancer","volume":"5","author":"Xie","year":"2020","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.biopha.2023.115663_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114714","article-title":"The therapeutic triad of extracellular vesicles: as drug targets, as drugs, and as drug carriers","volume":"192","author":"Moloudizargari","year":"2021","journal-title":"Biochem Pharm."},{"key":"10.1016\/j.biopha.2023.115663_bib8","first-page":"1730","article-title":"Concise review: developing best-practice models for the therapeutic use of extracellular vesicles","volume":"Vol. 6","author":"Reiner","year":"2017"},{"issue":"7","key":"10.1016\/j.biopha.2023.115663_bib9","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1152\/ajpcell.00228.2013","article-title":"Extracellular membrane vesicles as a mechanism of cell-to-cell communication: advantages and disadvantages","volume":"306","author":"Turturici","year":"2014","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"2","key":"10.1016\/j.biopha.2023.115663_bib10","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1007\/s12035-014-9054-5","article-title":"Exosomes as a nanodelivery system: a key to the future of neuromedicine?","volume":"53","author":"Aryani","year":"2016","journal-title":"Mol. Neurobiol."},{"issue":"4","key":"10.1016\/j.biopha.2023.115663_bib11","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.apsb.2016.02.001","article-title":"Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challenges","volume":"6","author":"Ha","year":"2016","journal-title":"Acta Pharm. Sin. B."},{"issue":"1","key":"10.1016\/j.biopha.2023.115663_bib12","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1080\/10717544.2022.2142700","article-title":"Luteolin-loaded exosomes derived from bone marrow mesenchymal stem cells: a promising therapy for liver fibrosis","volume":"29","author":"Ashour","year":"2022","journal-title":"Drug Deliv."},{"key":"10.1016\/j.biopha.2023.115663_bib13","unstructured":"Nipate S.S. \"EVALUATION OF ANTI-ARTHRITIC POTENTIAL OF DENDROPHTHOE FALCATA LIINN. LEAVES USING ISOLATED EXOSOMES AS DRUG CARRIER. Available from: \u3008https:\/\/ssrn.com\/abstract=4555717\u3009."},{"issue":"5","key":"10.1016\/j.biopha.2023.115663_bib14","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.3390\/pharmaceutics14051068","article-title":"Extracellular vesicles from M1-polarized macrophages combined with hyaluronic acid and a \u03b2-blocker potentiate Doxorubicin\u2019s antitumor activity by downregulating tumor-associated macrophages in breast cancer","volume":"14","author":"Jorquera-Cordero","year":"2022","journal-title":"Pharmaceutics"},{"issue":"8","key":"10.1016\/j.biopha.2023.115663_bib15","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.3390\/ijms20081848","article-title":"Extracellular vesicles as biological shuttles for targeted therapies","volume":"20","author":"Raimondo","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2023.115663_bib16","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.3389\/fimmu.2018.01534","article-title":"Therapeutic prospects of extracellular vesicles in cancer treatment","volume":"9","author":"Chulpanova","year":"2018","journal-title":"Front Immunol."},{"key":"10.1016\/j.biopha.2023.115663_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110771","article-title":"Enhanced exosome-mediated delivery of black bean phytochemicals (Phaseolus vulgaris L.) for cancer treatment applications","volume":"131","author":"Donoso-Quezada","year":"2020","journal-title":"Biomed. Pharmacother."},{"issue":"11","key":"10.1016\/j.biopha.2023.115663_bib18","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.3390\/pharmaceutics12111022","article-title":"Exploiting the natural properties of extracellular vesicles in targeted delivery towards specific cells and tissues","volume":"12","author":"Lara","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2023.115663_bib19","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3389\/fimmu.2020.00221","article-title":"Engineered tumor-derived extracellular vesicles: potentials in cancer immunotherapy","volume":"11","author":"Taghikhani","year":"2020","journal-title":"Front Immunol."},{"key":"10.1016\/j.biopha.2023.115663_bib20","doi-asserted-by":"crossref","first-page":"518","DOI":"10.3389\/fimmu.2014.00518","article-title":"Immunotherapeutic potential of extracellular vesicles","volume":"5","author":"Zhang","year":"2014","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2023.115663_bib21","article-title":"Extracellular vesicles derived from macrophages display glycyl-tRNA synthetase 1 and exhibit anti-cancer activity","volume":"10","author":"Goughnour","year":"2020","journal-title":"J. Extra Vesicles"},{"key":"10.1016\/j.biopha.2023.115663_bib22","doi-asserted-by":"crossref","first-page":"614","DOI":"10.3389\/fimmu.2014.00614","article-title":"Molecular mechanisms that influence the macrophage M1\u2013M2 polarization balance","volume":"Vol. 5","author":"Wang","year":"2014","journal-title":"Front. Immunol."},{"issue":"14","key":"10.1016\/j.biopha.2023.115663_bib23","doi-asserted-by":"crossref","first-page":"4401","DOI":"10.1016\/j.biomaterials.2014.02.009","article-title":"Inhibition of hypoxia-induced proliferation of pulmonary arterial smooth muscle cells by a mTOR siRNA-loaded cyclodextrin nanovector","volume":"35","author":"Liu","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.biopha.2023.115663_bib24","doi-asserted-by":"crossref","DOI":"10.12703\/P6-13","article-title":"The M1 and M2 paradigm of macrophage activation: time for reassessment","author":"Martinez","year":"2014","journal-title":"F1000Prime Rep."},{"key":"10.1016\/j.biopha.2023.115663_bib25","article-title":"M1 and M2 macrophage polarization and potentially therapeutic naturally occurring compounds","author":"Wang","year":"2019","journal-title":"Int. Immunopharmacol."},{"issue":"4","key":"10.1016\/j.biopha.2023.115663_bib26","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.ccell.2015.02.015","article-title":"Macrophages and therapeutic resistance in cancer","volume":"27","author":"Ruffell","year":"2015","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.biopha.2023.115663_bib27","first-page":"581","article-title":"Tumor-infiltrating M2 macrophages driven by specific genomic alterations are associated with prognosis in bladder cancer","volume":"42","author":"Xue","year":"2019","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.biopha.2023.115663_bib28","article-title":"Ceramide and palmitic acid inhibit macrophage-mediated epithelial\u2013mesenchymal transition in colorectal cancer","author":"de Araujo Junior","year":"2020","journal-title":"Mol. Cell Biochem"},{"issue":"11","key":"10.1016\/j.biopha.2023.115663_bib29","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1111\/bph.15373","article-title":"STAT3\/NF-\u03baB signalling disruption in M2 tumour-associated macrophages is a major target of PLGA nanocarriers\/PD-L1 antibody immunomodulatory therapy in breast cancer","volume":"178","author":"Cavalcante","year":"2021","journal-title":"Br. J. Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2023.115663_bib30","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.immuni.2011.07.002","article-title":"The role of retinoic acid in tolerance and immunity","volume":"35","author":"Hall","year":"2011","journal-title":"Immunity"},{"issue":"10","key":"10.1016\/j.biopha.2023.115663_bib31","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1038\/s41401-019-0262-4","article-title":"Inhibition of M2-like macrophages by all-trans retinoic acid prevents cancer initiation and stemness in osteosarcoma cells","volume":"40","author":"Shao","year":"2019","journal-title":"Acta Pharm. Sin."},{"key":"10.1016\/j.biopha.2023.115663_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2023.101647","article-title":"Retinoic acid-loaded PLGA nanocarriers targeting cell cholesterol potentialize the antitumour effect of PD-L1 antibody by preventing epithelial-mesenchymal transition mediated by M2-TAM in colorectal cancer","volume":"31","author":"J\u00fanior","year":"2023","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.biopha.2023.115663_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2017.05.123","article-title":"Libidibia ferrea presents antiproliferative, apoptotic and antioxidant effects in a colorectal cancer cell line","author":"Guerra","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.biopha.2023.115663_bib34","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12906-019-2454-3","article-title":"Crude extract from Libidibia ferrea (Mart. ex. Tul.) L.P. Queiroz leaves decreased intra articular inflammation induced by zymosan in rats","volume":"19","author":"Falc\u00e3o","year":"2019","journal-title":"BMC Complement Alter. Med."},{"issue":"2","key":"10.1016\/j.biopha.2023.115663_bib35","first-page":"387","article-title":"Ellagic acid holds promise against hepatocellular carcinoma in an experimental model: mechanisms of action","volume":"19","author":"Zaazaa","year":"2018","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"1","key":"10.1016\/j.biopha.2023.115663_bib36","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1743-7075-6-33","article-title":"Anti-inflammatory and anti-coagulatory activities of caffeic acid and ellagic acid in cardiac tissue of diabetic mice","volume":"6","author":"Chao","year":"2009","journal-title":"Nutr. Metab."},{"issue":"1","key":"10.1016\/j.biopha.2023.115663_bib37","doi-asserted-by":"crossref","first-page":"3.22.1","DOI":"10.1002\/0471143030.cb0322s30","article-title":"Isolation and characterization of exosomes from cell culture supernatants and biological fluids","volume":"30","author":"Th\u00e9ry","year":"2006","journal-title":"Curr. Protoc. Cell Biol."},{"key":"10.1016\/j.biopha.2023.115663_bib38","first-page":"12","article-title":"Exosomes as drug delivery system in gastrointestinal cancer","author":"Xie","year":"2023","journal-title":"Front Oncol."},{"key":"10.1016\/j.biopha.2023.115663_bib39","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jconrel.2015.09.031","article-title":"Microvesicle- and exosome-mediated drug delivery enhances the cytotoxicity of Paclitaxel in autologous prostate cancer cells","volume":"220","author":"Saari","year":"2015","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/j.biopha.2023.115663_bib40","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/hep.28549","article-title":"Tumor-derived exosomes elicit tumor suppression in murine hepatocellular carcinoma models and humans in vitro","volume":"64","author":"Rao","year":"2016","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.biopha.2023.115663_bib41","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12951-020-0573-0","article-title":"Gold nanoparticle based double-labeling of melanoma extracellular vesicles to determine the specificity of uptake by cells and preferential accumulation in small metastatic lung tumors","volume":"18","author":"Lara","year":"2020","journal-title":"J. Nanobiotechnol."},{"issue":"10","key":"10.1016\/j.biopha.2023.115663_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13101547","article-title":"Huis In \u2018T Veld R V., Jorquera-Cordero C, Chan AB, Ossendorp F, Cruz LJ. Zinc-phthalocyanine-loaded extracellular vesicles increase efficacy and selectivity of photodynamic therapy in co-culture and preclinical models of colon cancer","volume":"13","author":"Lara","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2023.115663_bib43","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jconrel.2015.09.031","article-title":"Microvesicle- and exosome-mediated drug delivery enhances the cytotoxicity of Paclitaxel in autologous prostate cancer cells","volume":"220","author":"Saari","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2023.115663_bib44","article-title":"Amino acid analyses of the exosome-eluted fractions from human serum by HPLC with fluorescence detection","volume":"12","author":"Onozato","year":"2018","journal-title":"Pr. Lab Med. [Internet]"},{"issue":"19","key":"10.1016\/j.biopha.2023.115663_bib45","doi-asserted-by":"crossref","first-page":"4713","DOI":"10.1007\/s00216-020-02728-z","article-title":"Solid-phase extraction of exosomes from diverse matrices via a polyester capillary-channeled polymer (C-CP) fiber stationary phase in a spin-down tip format","volume":"412","author":"Jackson","year":"2020","journal-title":"Anal. Bioanal. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2023.115663_bib46","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s12943-017-0742-4","article-title":"Factors involved in cancer metastasis: a better understanding to \u201cseed and soil\u201d hypothesis","volume":"16","author":"Liu","year":"2017","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.biopha.2023.115663_bib47","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12943-016-0564-9","article-title":"Lipocalin2 suppresses metastasis of colorectal cancer by attenuating NF-\u03baB-dependent activation of snail and epithelial mesenchymal transition","volume":"15","author":"Feng","year":"2016","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.biopha.2023.115663_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2022.213270","article-title":"Effective breast cancer therapy based on palmitic acid-loaded PLGA nanoparticles","volume":"145","author":"He","year":"2023","journal-title":"Biomater. Adv."},{"issue":"5","key":"10.1016\/j.biopha.2023.115663_bib49","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.ccr.2014.03.021","article-title":"A positive feedback loop between mesenchymal-like cancer cells and macrophages is essential to breast cancer metastasis","volume":"25","author":"Su","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.biopha.2023.115663_bib50","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.ccell.2015.02.015","article-title":"Macrophages and therapeutic resistance in cancer","volume":"Vol. 27","author":"Ruffell","year":"2015","journal-title":"Cancer Cell. Cell. Press"},{"key":"10.1016\/j.biopha.2023.115663_bib51","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1172\/JCI59643","article-title":"Macrophage plasticity and polarization: In vivo veritas","volume":"Vol. 122","author":"Sica","year":"2012","journal-title":"J. Clin. Investig."},{"issue":"11","key":"10.1016\/j.biopha.2023.115663_bib52","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1111\/cas.13065","article-title":"An IL-27\/Stat3 axis induces expression of programmed cell death 1 ligands (PD-L1\/2) on infiltrating macrophages in lymphoma","volume":"107","author":"Horlad","year":"2016","journal-title":"Cancer Sci."},{"issue":"7629","key":"10.1016\/j.biopha.2023.115663_bib53","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nature19834","article-title":"PI3K\u03b3 3 is a molecular switch that controls immune suppression","volume":"539","author":"Kaneda","year":"2016","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.biopha.2023.115663_bib54","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S1471-4906(03)00139-X","article-title":"PI3K and negative regulation of TLR signaling","volume":"24","author":"Fukao","year":"2003","journal-title":"Trends Immunol."},{"key":"10.1016\/j.biopha.2023.115663_bib55","first-page":"286","article-title":"Control of macrophage metabolism and activation by mTOR and Akt signaling","volume":"Vol. 27","author":"Covarrubias","year":"2015"},{"issue":"3","key":"10.1016\/j.biopha.2023.115663_bib56","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s13402-021-00594-0","article-title":"Role of TGF-\u03b2 in pancreatic ductal adenocarcinoma progression and PD-L1 expression","volume":"44","author":"Hussain","year":"2021","journal-title":"Cell. Oncol."},{"key":"10.1016\/j.biopha.2023.115663_bib57","first-page":"12","article-title":"Intratumoral macrophages contribute to epithelial-mesenchymal transition in solid tumors","author":"Bonde","year":"2012","journal-title":"BMC Cancer"},{"issue":"8","key":"10.1016\/j.biopha.2023.115663_bib58","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1158\/0008-5472.CAN-14-3016","article-title":"IL10 and PD-1 cooperate to limit the activity of tumor-specific CD8+ T cells","volume":"75","author":"Sun","year":"2015","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.biopha.2023.115663_bib59","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1016\/j.biomaterials.2013.11.083","article-title":"A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy","volume":"35","author":"Tian","year":"2014","journal-title":"Biomaterials"},{"issue":"18","key":"10.1016\/j.biopha.2023.115663_bib60","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.2217\/nnm-2016-0154","article-title":"Exosomes increase the therapeutic index of doxorubicin in breast and ovarian cancer mouse models","volume":"11","author":"Hadla","year":"2016","journal-title":"Nanomedicin"},{"issue":"6","key":"10.1016\/j.biopha.2023.115663_bib61","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1007\/s11095-014-1593-y","article-title":"Exosome delivered anticancer drugs across the blood-brain barrier for brain cancer therapy in Danio rerio","volume":"32","author":"Yang","year":"2015","journal-title":"Pharm. Res."},{"issue":"3","key":"10.1016\/j.biopha.2023.115663_bib62","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.nano.2015.10.012","article-title":"Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells","volume":"12","author":"Kim","year":"2016","journal-title":"Nanomedicine"},{"issue":"10","key":"10.1016\/j.biopha.2023.115663_bib63","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1038\/mt.2011.164","article-title":"Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain","volume":"19","author":"Zhuang","year":"2011","journal-title":"Mol. Ther."},{"issue":"9","key":"10.1016\/j.biopha.2023.115663_bib64","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1038\/mt.2010.105","article-title":"A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes","volume":"18","author":"Sun","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.biopha.2023.115663_bib65","article-title":"Immunotherapeutic potential of extracellular vesicles","volume":"5","author":"Zhang","year":"2014","journal-title":"Front Immunol. [Internet]"},{"key":"10.1016\/j.biopha.2023.115663_bib66","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.tox.2017.01.001","article-title":"Comparison of fluorescence-based methods to determine nanoparticle uptake by phagocytes and non-phagocytic cells in vitro","volume":"378","author":"Claudia","year":"2017","journal-title":"Toxicology"},{"issue":"3","key":"10.1016\/j.biopha.2023.115663_bib67","doi-asserted-by":"crossref","first-page":"538","DOI":"10.3390\/ijms18030538","article-title":"Exosomes: from garbage bins to promising therapeutic targets","volume":"18","author":"H Rashed","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.biopha.2023.115663_bib68","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1016\/j.biomaterials.2013.11.083","article-title":"A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy","volume":"35","author":"Tian","year":"2014","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.biopha.2023.115663_bib69","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.3892\/mmr.2020.11211","article-title":"Siva-1 regulates multidrug resistance of gastric cancer by targeting MDR1 and MRP1 via the NF-KB pathway","volume":"22","author":"Kong","year":"2020","journal-title":"Mol. Med. Rep."},{"issue":"3","key":"10.1016\/j.biopha.2023.115663_bib70","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1158\/1535-7163.MCT-19-0656","article-title":"PIN1 inhibition sensitizes chemotherapy in gastric cancer cells by targeting stem cell\u2013like traits and multiple biomarkers","volume":"19","author":"Zhang","year":"2020","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.biopha.2023.115663_bib71","first-page":"399","article-title":"Survivin as a novel target protein for reducing the proliferation of cancer cells (review)","volume":"Vol. 8","author":"Li","year":"2018","journal-title":"Biomed. Rep. Spandidos Publ."},{"issue":"8","key":"10.1016\/j.biopha.2023.115663_bib72","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1172\/JCI200422222","article-title":"Mitochondrial survivin inhibits apoptosis and promotes tumorigenesis","volume":"114","author":"Dohi","year":"2004","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.biopha.2023.115663_bib73","article-title":"The impact of the tumor microenvironment on macrophage polarization in cancer metastatic progression","volume":"Vol. 22","author":"Wang","year":"2021","journal-title":"Int. J. Mol. Sci. MDPI"},{"issue":"3","key":"10.1016\/j.biopha.2023.115663_bib74","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1007\/s13277-013-0725-z","article-title":"CXCR4-mediated Stat3 activation is essential for CXCL12-induced cell invasion in bladder cancer","volume":"34","author":"Shen","year":"2013","journal-title":"Tumor Biol."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223014610?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223014610?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T21:14:17Z","timestamp":1779916457000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332223014610"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":74,"alternative-id":["S0753332223014610"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115663","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of murine colorectal cancer metastasis by targeting M2-TAM through STAT3\/NF-kB\/AKT signaling using macrophage 1-derived extracellular vesicles loaded with oxaliplatin, retinoic acid, and Libidibia ferrea","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115663","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"115663"}}